Berberine and Folic Acid: study protocols
5 study groups took Berberine together with Folic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Berberine
5 study groups in 5 studies say how much Berberine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mg to 500 mg, 100% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mg to 500 mg | 5 |
Dose per serving from research: Folic Acid
5 study groups in 5 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mcg to 250 mcg, 100% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 5 |
Commonly used together
5 of 5 study groups took Berberine and Folic Acid with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Coenzyme Q10 | 5 |
| Policosanol | 5 |
| Astaxanthin | 4 |
| Red Yeast Rice | 4 |
5 study groups
| Study | ||||
|---|---|---|---|---|
| Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial 2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant | 500 mg | 200 mcg | 4 weeks | 23 |
| Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study 2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia | 500 mg | 200 mcg | 4 weeks | — |
| Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial 2019 · Armolipid Plus (AP) · Adults aged 18–70 with metabolic syndrome and left ventricular hypertrophy; men and women | 500 mg | 200 mcg | 24 weeks | 71 |
| Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial 2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment | 500 mg | 200 mcg | 12 weeks | 51 |
| Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial 2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded. | 500 mg | 200 mcg | 6 weeks | 23 |